Acute Effects of TENS on Cervical Muscle Stiffness and Pain in Neck Pain
Enrolling by invitationNot applicableNCT07244861
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This randomized controlled trial investigates the acute effects of transcutaneous electrical nerve stimulation (TENS) on passive cervical muscle stiffness (MyotonPro "dynamic stiffness", N/m) and pain (0-10 VAS) in adults with chronic/mechanical neck pain. Participants will be allocated 1:1 to TENS or control/sham. Outcomes are measured immediately before and immediately after a single 15-minute session.
Study details
- Official title
- Acute Effects of Transcutaneous Electrical Nerve Stimulation on Passive Muscle Stiffness and Pain in Patients With Neck Pain: A Randomized Controlled Trial
- Conditions
- Neck Pain
- Chronic Neck Pain
- Muscle Stiffness
- Transcutaneous Electrical Nerve Stimulation
- Interventions
- Device: Transcutaneous Electrical Nerve Stimulation
- Device: Sham TENS
- Sponsor
- Erzurum Technical University
- Collaborators
- Amasya University; Bangor University; Ataturk University
- Start date
- 2025-09-23
- Primary completion
- 2025-12-10
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 18-50 years. Neck pain VAS ≥ 3/10 at screening and on test day. Clinical diagnosis of chronic or mechanical neck pain (≥6 weeks). Able to understand study procedures and provide written informed consent. Willing to refrain from analgesics/muscle relaxants and vigorous neck/shoulder exercise for 24 hours before testing. Exclusion Criteria: * Cervical radiculopathy or neurological signs (myotomal weakness, dermatomal sensory loss, reflex changes). Recent invasive procedures to the neck/shoulder (e.g., surgery, injections, radiofrequency/neurotomy) within 6 weeks. Pacemaker/implantable cardioverter, or other active implanted electronic device. Pregnancy or planning pregnancy. Skin conditions at electrode sites (open wounds, infection, severe dermatitis) or known allergy to electrode adhesive/gel. History of epilepsy or unexplained syncope. Acute neck trauma (\<6 weeks) or red flags (fracture, malignancy, infection, inflammatory rheumatic disease). Systemic disorders likely to affect outcomes (e.g., uncontrolled diabetes with neuropathy, severe cardiovascular disease, fibromyalgia with widespread pain). Ongoing electrotherapy to the neck region or botulinum toxin injections to cervical muscles within 3 months. Inability to comply with procedures (e.g., severe communication/cognitive impairment), or insufficient proficiency in Turkish to complete measures.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07244861